Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare...
LUGANO, Switzerland--(BUSINESS WIRE)--Feb 19, 2019--GT Gain Therapeutics SA today announces that it has closed a 2.5 Million series A financing with VitaTech S.A. (1.1Mio), Helsinn…
